cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-06-15

AUTHORS

Linda S. Hoffmann, Horng H. Chen

ABSTRACT

Essential physiological homeostatic processes such as vascular tone, fluid balance, cardiorenal function, and sensory processes are regulated by the second messenger cyclic guanosine 3′, 5′-monophosphate (cGMP). Dysregulation of cGMP-dependent pathways plays an important role in cardiovascular diseases such as hypertension, pulmonary hypertension, heart failure, or erectile dysfunction. Thus, the cGMP pathway consisting of the cGMP-generating guanylyl cyclases, protein kinases, and phosphodiesterases (PDE) has evolved to an important drug target and is the focus of a wide variety of research fields ranging from unraveling mechanisms on the molecular level to understanding the regulation of physiological and pathophysiological processes by cGMP. Based on the results from basic and preclinical research, therapeutic drugs have been developed which modulate the cGMP pathway and are investigated in clinical trials. Riociguat, a nitric oxide (NO)-independent soluble guanylyl cyclase stimulator; recombinant B-type natriuretic peptide (BNP); or recombinant atrial natriuretic peptide (ANP) and PDE5 inhibitors are cGMP-modulating drugs that are already available for the treatment of pulmonary hypertension, acute heart failure, and erectile dysfunction, respectively. The latest results from basic to clinical research on cGMP were presented on the 6th International Conference on cGMP in Erfurt, Germany, and are summarized in this article. More... »

PAGES

707-718

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8

DOI

http://dx.doi.org/10.1007/s00210-014-0999-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015087696

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24927824


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacteria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic GMP", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanylate Cyclase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitric Oxide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Conformation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Cytoplasmic and Nuclear", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Soluble Guanylyl Cyclase", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Pharmacology and Toxicology, Biomedical Center, University of Bonn, Bonn, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10388.32", 
          "name": [
            "Institute of Pharmacology and Toxicology, Biomedical Center, University of Bonn, Bonn, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoffmann", 
        "givenName": "Linda S.", 
        "id": "sg:person.0706501475.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706501475.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm1175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045090677", 
          "https://doi.org/10.1038/nm1175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010869395", 
          "https://doi.org/10.1038/nm.2634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11897-010-0045-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049497981", 
          "https://doi.org/10.1007/s11897-010-0045-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature10405", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000059117", 
          "https://doi.org/10.1038/nature10405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2603", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032744556", 
          "https://doi.org/10.1038/nm.2603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms2626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005173982", 
          "https://doi.org/10.1038/ncomms2626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035621233", 
          "https://doi.org/10.1038/ng.328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature12722", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012295459", 
          "https://doi.org/10.1038/nature12722"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-06-15", 
    "datePublishedReg": "2014-06-15", 
    "description": "Essential physiological homeostatic processes such as vascular tone, fluid balance, cardiorenal function, and sensory processes are regulated by the second messenger cyclic guanosine 3\u2032, 5\u2032-monophosphate (cGMP). Dysregulation of cGMP-dependent pathways plays an important role in cardiovascular diseases such as hypertension, pulmonary hypertension, heart failure, or erectile dysfunction. Thus, the cGMP pathway consisting of the cGMP-generating guanylyl cyclases, protein kinases, and phosphodiesterases (PDE) has evolved to an important drug target and is the focus of a wide variety of research fields ranging from unraveling mechanisms on the molecular level to understanding the regulation of physiological and pathophysiological processes by cGMP. Based on the results from basic and preclinical research, therapeutic drugs have been developed which modulate the cGMP pathway and are investigated in clinical trials. Riociguat, a nitric oxide (NO)-independent soluble guanylyl cyclase stimulator; recombinant B-type natriuretic peptide (BNP); or recombinant atrial natriuretic peptide (ANP) and PDE5 inhibitors are cGMP-modulating drugs that are already available for the treatment of pulmonary hypertension, acute heart failure, and erectile dysfunction, respectively. The latest results from basic to clinical research on cGMP were presented on the 6th International Conference on cGMP in Erfurt, Germany, and are summarized in this article.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00210-014-0999-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015404", 
        "issn": [
          "0028-1298", 
          "1432-1912"
        ], 
        "name": "Naunyn-Schmiedeberg's Archives of Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "387"
      }
    ], 
    "keywords": [
      "atrial natriuretic peptide", 
      "pulmonary hypertension", 
      "heart failure", 
      "erectile dysfunction", 
      "natriuretic peptide", 
      "cGMP pathway", 
      "soluble guanylyl cyclase stimulator", 
      "acute heart failure", 
      "type natriuretic peptide", 
      "recombinant atrial natriuretic peptide", 
      "second messenger cyclic guanosine 3", 
      "cyclic guanosine 3", 
      "cGMP-dependent pathway", 
      "cardiorenal function", 
      "cGMP generators", 
      "vascular tone", 
      "clinical trials", 
      "cardiovascular disease", 
      "fluid balance", 
      "cyclase stimulator", 
      "PDE5 inhibitors", 
      "therapeutic implications", 
      "pathophysiological processes", 
      "hypertension", 
      "preclinical research", 
      "nitric oxide", 
      "clinical research", 
      "therapeutic drugs", 
      "guanosine 3", 
      "cGMP", 
      "dysfunction", 
      "homeostatic processes", 
      "drug targets", 
      "important drug targets", 
      "drugs", 
      "guanylyl cyclases", 
      "sensory processes", 
      "pathway", 
      "latest results", 
      "riociguat", 
      "failure", 
      "protein kinase", 
      "peptides", 
      "disease", 
      "phosphodiesterases", 
      "bedside", 
      "important role", 
      "trials", 
      "dysregulation", 
      "stimulator", 
      "treatment", 
      "inhibitors", 
      "tone", 
      "report", 
      "molecular level", 
      "International Conference", 
      "effectors", 
      "kinase", 
      "target", 
      "levels", 
      "wide variety", 
      "role", 
      "regulation", 
      "Erfurt", 
      "results", 
      "mechanism", 
      "cyclases", 
      "function", 
      "conference", 
      "balance", 
      "research", 
      "implications", 
      "focus", 
      "variety", 
      "Germany", 
      "bench", 
      "article", 
      "process", 
      "oxide", 
      "research field", 
      "transition", 
      "field", 
      "generator", 
      "Essential physiological homeostatic processes", 
      "physiological homeostatic processes", 
      "messenger cyclic guanosine 3\u2032", 
      "independent soluble guanylyl cyclase stimulator", 
      "guanylyl cyclase stimulator"
    ], 
    "name": "cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications", 
    "pagination": "707-718", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015087696"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00210-014-0999-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24927824"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00210-014-0999-8", 
      "https://app.dimensions.ai/details/publication/pub.1015087696"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_642.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00210-014-0999-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      22 PREDICATES      131 URIs      115 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00210-014-0999-8 schema:about N20050f4c6eb74a7786546c2156dc9d83
2 N324fa76ba0824ee0aff0a33615c58059
3 N4795eedcd5f74523a817520d966c2f92
4 N6578fda40eb043d7ae8dcba5ca4f03ea
5 N6adb996b31874d7ba7ab1643687c4374
6 N922a85f835b34833894f59eceac8fdaa
7 Nb214e4a5319b42bc867ddc876f9382ed
8 Nccf7399f06b04144a23d577aed4b41de
9 Nd54b160c28f14273ac7ee9b8e0f9f55a
10 Ne0d424e3180d468e829ea0c3bfc597a5
11 anzsrc-for:11
12 anzsrc-for:1102
13 schema:author N159fbdb02ac84a20beb4b513a79a4553
14 schema:citation sg:pub.10.1007/s11897-010-0045-1
15 sg:pub.10.1038/nature10405
16 sg:pub.10.1038/nature12722
17 sg:pub.10.1038/ncomms2626
18 sg:pub.10.1038/ng.328
19 sg:pub.10.1038/nm.2603
20 sg:pub.10.1038/nm.2634
21 sg:pub.10.1038/nm1175
22 schema:datePublished 2014-06-15
23 schema:datePublishedReg 2014-06-15
24 schema:description Essential physiological homeostatic processes such as vascular tone, fluid balance, cardiorenal function, and sensory processes are regulated by the second messenger cyclic guanosine 3′, 5′-monophosphate (cGMP). Dysregulation of cGMP-dependent pathways plays an important role in cardiovascular diseases such as hypertension, pulmonary hypertension, heart failure, or erectile dysfunction. Thus, the cGMP pathway consisting of the cGMP-generating guanylyl cyclases, protein kinases, and phosphodiesterases (PDE) has evolved to an important drug target and is the focus of a wide variety of research fields ranging from unraveling mechanisms on the molecular level to understanding the regulation of physiological and pathophysiological processes by cGMP. Based on the results from basic and preclinical research, therapeutic drugs have been developed which modulate the cGMP pathway and are investigated in clinical trials. Riociguat, a nitric oxide (NO)-independent soluble guanylyl cyclase stimulator; recombinant B-type natriuretic peptide (BNP); or recombinant atrial natriuretic peptide (ANP) and PDE5 inhibitors are cGMP-modulating drugs that are already available for the treatment of pulmonary hypertension, acute heart failure, and erectile dysfunction, respectively. The latest results from basic to clinical research on cGMP were presented on the 6th International Conference on cGMP in Erfurt, Germany, and are summarized in this article.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree false
28 schema:isPartOf N33041c0ae031442887ff2bf6c0fdda31
29 N69d071d24c5d4685ab15004aa0ee54f1
30 sg:journal.1015404
31 schema:keywords Erfurt
32 Essential physiological homeostatic processes
33 Germany
34 International Conference
35 PDE5 inhibitors
36 acute heart failure
37 article
38 atrial natriuretic peptide
39 balance
40 bedside
41 bench
42 cGMP
43 cGMP generators
44 cGMP pathway
45 cGMP-dependent pathway
46 cardiorenal function
47 cardiovascular disease
48 clinical research
49 clinical trials
50 conference
51 cyclase stimulator
52 cyclases
53 cyclic guanosine 3
54 disease
55 drug targets
56 drugs
57 dysfunction
58 dysregulation
59 effectors
60 erectile dysfunction
61 failure
62 field
63 fluid balance
64 focus
65 function
66 generator
67 guanosine 3
68 guanylyl cyclase stimulator
69 guanylyl cyclases
70 heart failure
71 homeostatic processes
72 hypertension
73 implications
74 important drug targets
75 important role
76 independent soluble guanylyl cyclase stimulator
77 inhibitors
78 kinase
79 latest results
80 levels
81 mechanism
82 messenger cyclic guanosine 3′
83 molecular level
84 natriuretic peptide
85 nitric oxide
86 oxide
87 pathophysiological processes
88 pathway
89 peptides
90 phosphodiesterases
91 physiological homeostatic processes
92 preclinical research
93 process
94 protein kinase
95 pulmonary hypertension
96 recombinant atrial natriuretic peptide
97 regulation
98 report
99 research
100 research field
101 results
102 riociguat
103 role
104 second messenger cyclic guanosine 3
105 sensory processes
106 soluble guanylyl cyclase stimulator
107 stimulator
108 target
109 therapeutic drugs
110 therapeutic implications
111 tone
112 transition
113 treatment
114 trials
115 type natriuretic peptide
116 variety
117 vascular tone
118 wide variety
119 schema:name cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications
120 schema:pagination 707-718
121 schema:productId N4a3d13453e8a455aa96a263751452d99
122 N6b314272a97f4d9f87016269b7c4807d
123 Ndcd2945042064986a36e9af394ee149e
124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015087696
125 https://doi.org/10.1007/s00210-014-0999-8
126 schema:sdDatePublished 2022-01-01T18:34
127 schema:sdLicense https://scigraph.springernature.com/explorer/license/
128 schema:sdPublisher N36a791b4d25848ad83ffade1485020fa
129 schema:url https://doi.org/10.1007/s00210-014-0999-8
130 sgo:license sg:explorer/license/
131 sgo:sdDataset articles
132 rdf:type schema:ScholarlyArticle
133 N159fbdb02ac84a20beb4b513a79a4553 rdf:first sg:person.0706501475.50
134 rdf:rest N6d1a3f3d97254c888de646d40c21fcb3
135 N20050f4c6eb74a7786546c2156dc9d83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Nitric Oxide
137 rdf:type schema:DefinedTerm
138 N324fa76ba0824ee0aff0a33615c58059 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Guanylate Cyclase
140 rdf:type schema:DefinedTerm
141 N33041c0ae031442887ff2bf6c0fdda31 schema:volumeNumber 387
142 rdf:type schema:PublicationVolume
143 N36a791b4d25848ad83ffade1485020fa schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 N4795eedcd5f74523a817520d966c2f92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Animals
147 rdf:type schema:DefinedTerm
148 N4a3d13453e8a455aa96a263751452d99 schema:name doi
149 schema:value 10.1007/s00210-014-0999-8
150 rdf:type schema:PropertyValue
151 N6578fda40eb043d7ae8dcba5ca4f03ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Receptors, Cytoplasmic and Nuclear
153 rdf:type schema:DefinedTerm
154 N69d071d24c5d4685ab15004aa0ee54f1 schema:issueNumber 8
155 rdf:type schema:PublicationIssue
156 N6adb996b31874d7ba7ab1643687c4374 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Cyclic GMP
158 rdf:type schema:DefinedTerm
159 N6b314272a97f4d9f87016269b7c4807d schema:name dimensions_id
160 schema:value pub.1015087696
161 rdf:type schema:PropertyValue
162 N6d1a3f3d97254c888de646d40c21fcb3 rdf:first sg:person.01024326700.50
163 rdf:rest rdf:nil
164 N922a85f835b34833894f59eceac8fdaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Protein Conformation
166 rdf:type schema:DefinedTerm
167 Nb214e4a5319b42bc867ddc876f9382ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Soluble Guanylyl Cyclase
169 rdf:type schema:DefinedTerm
170 Nccf7399f06b04144a23d577aed4b41de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Natriuretic Peptides
172 rdf:type schema:DefinedTerm
173 Nd54b160c28f14273ac7ee9b8e0f9f55a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 Ndcd2945042064986a36e9af394ee149e schema:name pubmed_id
177 schema:value 24927824
178 rdf:type schema:PropertyValue
179 Ne0d424e3180d468e829ea0c3bfc597a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Bacteria
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
186 schema:name Cardiorespiratory Medicine and Haematology
187 rdf:type schema:DefinedTerm
188 sg:journal.1015404 schema:issn 0028-1298
189 1432-1912
190 schema:name Naunyn-Schmiedeberg's Archives of Pharmacology
191 schema:publisher Springer Nature
192 rdf:type schema:Periodical
193 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
194 schema:familyName Chen
195 schema:givenName Horng H.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
197 rdf:type schema:Person
198 sg:person.0706501475.50 schema:affiliation grid-institutes:grid.10388.32
199 schema:familyName Hoffmann
200 schema:givenName Linda S.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706501475.50
202 rdf:type schema:Person
203 sg:pub.10.1007/s11897-010-0045-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049497981
204 https://doi.org/10.1007/s11897-010-0045-1
205 rdf:type schema:CreativeWork
206 sg:pub.10.1038/nature10405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000059117
207 https://doi.org/10.1038/nature10405
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/nature12722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012295459
210 https://doi.org/10.1038/nature12722
211 rdf:type schema:CreativeWork
212 sg:pub.10.1038/ncomms2626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005173982
213 https://doi.org/10.1038/ncomms2626
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/ng.328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035621233
216 https://doi.org/10.1038/ng.328
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/nm.2603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032744556
219 https://doi.org/10.1038/nm.2603
220 rdf:type schema:CreativeWork
221 sg:pub.10.1038/nm.2634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010869395
222 https://doi.org/10.1038/nm.2634
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/nm1175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045090677
225 https://doi.org/10.1038/nm1175
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.10388.32 schema:alternateName Institute of Pharmacology and Toxicology, Biomedical Center, University of Bonn, Bonn, Germany
228 schema:name Institute of Pharmacology and Toxicology, Biomedical Center, University of Bonn, Bonn, Germany
229 rdf:type schema:Organization
230 grid-institutes:grid.66875.3a schema:alternateName Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
231 schema:name Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...